vitalwiki

hydrocortisone and acetic acid

RxNorm 313786· HYDROCORTISONE AND ACETIC ACID OTIC· AURICULAR (OTIC)

Corticosteroid [EPC] · Saptalis Pharmaceuticals, LLC

Indications and usage

INDICATIONS AND USAGE: For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

Dosage and administration

DOSAGE AND ADMINISTRATION: Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

Warnings

WARNINGS: Discontinue promptly if sensitization or irritation occurs.

Contraindications

CONTRAINDICATIONS: Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Adverse events

Most frequently reported events (FDA FAERS). Report frequency does not imply causation.

  • asthenia5
  • covid-195
  • pain4
  • abdominal discomfort3
  • fall3
  • fatigue3
  • influenza3
  • urinary tract infection3
  • vomiting3
  • weight decreased3
  • arthralgia2
  • chest pain2
  • decreased appetite2
  • device dislocation2
  • dyspnoea2
  • glossodynia2

Adverse reactions (label)

ADVERSE REACTIONS: Stinging or burning may be noted occasionally; local irritation has occurred very rarely. To report SUSPECTED ADVERSE REACTIONS, contact Saptalis Pharmaceuticals, LLC at 1-833-727-8254 or FDA at 1-­800-FDA-1088 or www.fda.gov/medwatch .

KR · 한국Products in Korea (124)